| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 5,239,000 | 4,942,000 | 5,160,000 | 5,064,000 | | Cost of Revenue | 4,196,000 | 3,961,000 | 4,161,000 | 4,051,000 | | | Gross Profit | 1,043,000 | 981,000 | 999,000 | 1,013,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 822,000 | 648,000 | 737,000 | 648,000 | | Non Recurring |
-
|
-
| 25,000 | 24,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 221,000 | 333,000 | 237,000 | 341,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 22,000 | 6,000 | (18,000) | 29,000 | | Earnings Before Interest And Taxes | 243,000 | 339,000 | 276,000 | 360,000 | | Interest Expense | 76,000 | 89,000 | 99,000 | 106,000 | | Income Before Tax | 167,000 | 250,000 | 177,000 | 254,000 | | Income Tax Expense | 74,000 | 77,000 | 46,000 | 95,000 | | Minority Interest | (18,000) | (26,000) | (18,000) | (14,000) | | | | Net Income From Continuing Ops | 75,000 | 147,000 | 61,000 | 159,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (9,000) | 509,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 75,000 | 147,000 | 52,000 | 668,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $75,000 | $147,000 | $52,000 | $668,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
